Optimer Pharmaceuticals

Optimer board chairman McKinnell named CEO

Thursday, February 28, 2013 03:09 PM

The board of directors of Jersey City, N.J.-based Optimer Pharmaceuticals has appointed its chairman, Dr. Henry McKinnell, chief executive officer. McKinnell was Pfizer's CEO and chairman from 2001 to 2006 and was with Pfizer from 1971 until his retirement in 2007.

More... »


Optimer strips chairman of title, fires CFO and VP

Monday, April 9, 2012 11:26 AM

The board of directors of Optimer Pharmaceuticals, a San Diego-based biopharmaceutical company, has removed Michael Chang as chairman and terminated John D. Prunty, chief financial officer, and Dr. Youe-Kong Shue, vice president.

More... »


Astellas and Optimer collaborate on fidaxomicin in Japan

Monday, April 2, 2012 03:57 PM

San Diego-based Optimer Pharmaceuticals and Tokyo-based Astellas Pharma have formed an exclusive collaboration and license agreement to develop and commercialize fidaxomicin tablets in Japan for the treatment of Clostridium difficile infection (CDI) affecting the colon.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs